J. Craig Venter, a groundbreaking scientist renowned for his pivotal role in decoding the human genome and a trailblazer in modern genomics, passed away on Wednesday, as announced by his institute.
Subscribe to read this story without ads
Get unlimited access to ad-free articles and exclusive content.
He was 79 years old.
The J. Craig Venter Institute shared a statement on Wednesday confirming that he died in San Diego after being hospitalized due to cancer complications.
Venter was a pioneering scientist who significantly influenced the field of genomics. His institute asserted that he championed the idea that scientific advancements should provide “real-world impact.” He also played a crucial role in establishing synthetic biology.
Venter served as a naval officer in Vietnam from 1967 to 1968. He later earned his BS in biochemistry and PhD in physiology and pharmacology from the University of California, San Diego.
His influential research primarily focused on genomics. Venter stated that his institute “moved genome science from a slow, gene-by-gene discovery process to scalable, data-driven science, paving the way for demonstrated genome design and construction.”
Venter led efforts to create one of the first draft sequences of the human genome. His team published the first “high-quality” diploid human genome, emphasizing the importance of measuring genetic variations inherited from parents.
The human genome is a comprehensive set of genetic information, stored as DNA within nearly every cell nucleus in the body, as described by the J. Craig Venter Institute.
In the 1990s, Venter and his team at the National Institutes of Health developed expressed sequence tags (ESTs), which facilitated the rapid discovery of new genes.
In 1995, Venter and colleagues utilized “whole-genome shotgun sequencing” to sequence the DNA of Haemophilus influenzae, marking it as the first free-living organism analyzed.
In 1998, Venter co-founded Celera Genomics.
His team at Celera competed against the National Institutes of Health-supported Human Genome Project, which received funding from the US government and UK research partners.
As president of Celera in 2000, Venter and the public consortium announced they had compiled the first draft of the human genome, a landmark achievement in biological science.
Beyond genomics, Venter directed the Global Ocean Sampling Expedition in Metagenomics, revealing remarkable microbial diversity.
Scientists globally paid tribute to Venter, acknowledging his remarkable contributions to the field.
“Craig Venter was a force of nature, a controversial yet profoundly impactful figure,” remarked Sir John Hardy, a neuroscience professor at University College London. He stated in a press release. “The race to finish sequencing the human genome was marked by competition between American and British consortia. This rivalry undeniably accelerated the process, but ultimately, both teams published their findings simultaneously in Science and Nature.”
Dr. Roger Highfield, scientific director at the Science Museum Group, commented that Venter was an “adventurous and tireless pioneer” in genome sequencing and synthetic biology.
“I was in correspondence with him only weeks ago about a new writing project,” Highfield shared. He mentioned a recent diagnosis, but the news came as a shock. While Craig was a polarizing figure, he was undeniably passionate and driven by science.”
Throughout his illustrious career, Venter received numerous accolades, including the 2008 National Medal of Science, the 2002 Gardner Foundation International Award, the 2001 Paul Ehrlich and Ludwig Darmstaedter Awards, and the King Faisal International Science Award.
Source: www.nbcnews.com
